- Home
- WGS
as 08-14-2025 12:43pm EST
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | STAMFORD |
| Market Cap: | 2.4B | IPO Year: | N/A |
| Target Price: | $99.29 | AVG Volume (30 days): | 988.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.05 | EPS Growth: | N/A |
| 52 Week Low/High: | $28.86 - $123.11 | Next Earning Date: | 07-29-2025 |
| Revenue: | $362,321,000 | Revenue Growth: | 48.70% |
| Revenue Growth (this year): | 22.16% | Revenue Growth (next year): | 19.63% |
Latest GeneDx Holdings Corp. News
WGS Breaking Stock News: Dive into WGS Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 months ago
3 Stocks Estimated To Be Up To 48.8% Undervalued Offering A 32.6% Discount Opportunity
Motley Fool
2 months ago
Why GeneDX Stock Surged Higher This Week
Simply Wall St.
2 months ago
Three Stocks That May Be Trading Below Their Estimated Value In June 2025
Simply Wall St.
2 months ago
3 Stocks That May Be Undervalued In June 2025
Simply Wall St.
2 months ago
3 Stocks That May Be Trading Below Fair Value Estimates
Simply Wall St.
2 months ago
Lyft And 2 Additional Stocks Believed To Be Trading Below Fair Value
Business Wire
2 months ago
GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics
Simply Wall St.
2 months ago
GeneDx Holdings Corp.'s (NASDAQ:WGS) Profit Outlook
Compare WGS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "WGS GeneDx Holdings Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.